Clinical trial
A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of TPN171H in Patients With Erectile Dysfunction
NCT05188989 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of TPN171H in Patients With Erectile Dysfunction
- Lead sponsor
- Vigonvita Life Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2021
- Completion date
- February 14, 2023
- Enrollment
- 765 (actual)
- Sites
- 49
Conditions
As the registry lists them; a condition with its own page is linked.